Skip to content
Genialis logo — Know your patient, know your drug

Genialis

Know your patient, know your drug

Founded 2015 United States Boston, United States 31 employees Series A Total: $15.65M Biotechnology, Health Care +1

General Information

Company Name Genialis
Founded Year 2015
Location United States Boston, United States
Founders / Decision Makers
Team member
Employees 31
Industries Biotechnology, Health Care, Clean Energy
Funding Stage Series A
Business Model B2B, SaaS, API
Revenue Model Service Fee, Subscription, Licensing
Offices as of Nov 2026
‏Boston‏، ‏Massachusetts‏ ‏02111‏، ‏US‏, ‏Boston‏، ‏Massachusetts‏ ‏02111‏، ‏US‏ ‏Ljubljana‏، ‏1000‏، ‏SI‏, ‏Ljubljana‏، ‏1000‏، ‏SI‏
Social

BounceWatch is an independent company data service, not affiliated with Genialis. To contact Genialis, visit genialis.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Genialis compare?

A PDF of Genialis and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Genialis soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

Event Participation Nov 04, 2026

Genialis is participating in #SITC26 in Phoenix to present their abstract on tumor immune state predictors.

New Partnership Nov 02, 2026

Genialis collaborated with Inventia Life Science to explore bioprinted pancreatic cancer cells and interpret RNA-seq data using the Genialis Supermodel.

About Genialis

Genialis, operating under the motto "Know your patient, know your drug," is a pioneering figure in the field of precision oncology. Founded in 2015, this United States-based company is at the forefront of transforming healthcare by developing and validating clinically actionable biomarkers.

By leveraging one of the world's most ethnographically diverse cancer data sets, Genialis is significantly enhancing the predictability of patient responses to various treatment modalities, including targeted inhibitors and immunotherapies. Their approach not only informs better treatment decisions but also aims for the best possible outcomes for patients and their communities.

The company's innovative solutions have earned them the trust of prominent pharmaceutical and diagnostics partners. Their recent funding success—a $13.00M Series A investment secured in March 2023—was backed by investors such as First Star Ventures, The Group Ventures, Redalpine, Pikas, and Taiwania Capital, underscoring investor confidence in their mission and potential for sustainable growth.

Business keywords: Precision Oncology, Clinical Biomarker Discovery, Data Fusion, Biomedical Data Analysis, Omics Data Integration, Gene Signature, Predictive Biomarker, Precision Medicine, Computational Biology, Translational Research, Novel Drug Positioning, Clinical Development, Cancer Data Sets, Targeted Inhibitors

Services & Products

AI Foundation Model of Cancer Biology
Genialis Supermodel
Multiomics & Clinical Data Infrastructure
Therapeutic Intelligence

Target Customers

Pharmaceutical Companies Biotechnology Firms Oncologists Clinical Researchers

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Series A $13.00M 5
First Star Ventures, The Group Ventures +3
01 Mar 2023
Grant €200.00K 1
EUREKA Network Projects
01 Feb 2018
Seed $2.30M 3
First Star Ventures, Redalpine +1
01 Nov 2017
Grant €50.00K 1
European Commission
01 Feb 2015
Convertible Note €100.00K -
01 Sep 2013
Spinout Undisclosed 1
University Ventures
01 Feb 2013

Genialis Alternatives & Competitors

View All Alternatives
Genialis vs
Scailyte
Scailyte Switzerland

True precision medicine through single-cell science.

Series A
18 employees
AI, Biotechnology
Genialis vs

This page is no longer actively updated. For future updates follow: MindWalk Holdings Corp.

Grant
4 employees
Biotechnology, Life Sciences
Genialis vs

Ikena merged with ImageneBio on in July 2025. Please visit https://inmagenebio.com/ for more informa...

Post-IPO Equity
14 employees
Biotechnology, Health Care

FAQ About Genialis

Know your patient, know your drug
Genialis was founded in 2015.
Genialis is headquartered in Boston, United States. As of Nov 2026, it also has offices in ‏Boston‏، ‏Massachusetts‏ ‏02111‏، ‏US‏, ‏Boston‏، ‏Massachusetts‏ ‏02111‏، ‏US‏ and ‏Ljubljana‏، ‏1000‏، ‏SI‏, ‏Ljubljana‏، ‏1000‏، ‏SI‏.
Genialis operates in Biotechnology, Health Care and Clean Energy. Its work centres on Precision Oncology, Clinical Biomarker Discovery, Data Fusion and Biomedical Data Analysis. Its customers include Pharmaceutical Companies, Biotechnology Firms and Oncologists.
Genialis has a B2B, SaaS and API business model. Its revenue comes from Service Fee, Subscription and Licensing.
Genialis has approximately 31 employees.
Genialis has completed 6 funding rounds, raising a total of $15.65M. The latest funding stage is Series A.
Genialis offers: AI Foundation Model of Cancer Biology, Genialis Supermodel, Multiomics & Clinical Data Infrastructure, Therapeutic Intelligence.
Top alternatives and competitors to Genialis include Scailyte, MindWalk Corp. (formerly BioStrand), Ikena Oncology (Merged with ImageneBio), iLOF, Relay Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Genialis and Scailyte are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Genialis, https://bouncewatch.com/company/genialis, updated 5 November 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout